63 related articles for article (PubMed ID: 21619888)
1. Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters.
Chau DT; Ahmed J; Wang TT; Xie H; Dawson R; Green AI
Neuropharmacology; 2011 Sep; 61(4):646-52. PubMed ID: 21619888
[TBL] [Abstract][Full Text] [Related]
2. Clozapine reduces alcohol drinking in Syrian golden hamsters.
Green AI; Chau DT; Keung WM; Dawson R; Mesholam RI; Schildkraut JJ
Psychiatry Res; 2004 Aug; 128(1):9-20. PubMed ID: 15450910
[TBL] [Abstract][Full Text] [Related]
3. Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan.
Khokhar JY; Chau DT; Dawson R; Green AI
Drug Alcohol Depend; 2015 Jul; 152():277-81. PubMed ID: 25979645
[TBL] [Abstract][Full Text] [Related]
4. Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.
Gulick D; Chau DT; Khokhar JY; Dawson R; Green AI
Psychiatry Res; 2014 Aug; 218(3):329-34. PubMed ID: 24836200
[TBL] [Abstract][Full Text] [Related]
5. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
6. Desipramine enhances the ability of paliperidone to decrease alcohol drinking.
Chau DT; Khokhar JY; Gulick D; Dawson R; Green AI
J Psychiatr Res; 2015 Oct; 69():9-18. PubMed ID: 26343589
[TBL] [Abstract][Full Text] [Related]
7. Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters.
Chau DT; Gulick D; Xie H; Dawson R; Green AI
Neuropharmacology; 2010 Feb; 58(2):351-6. PubMed ID: 19895824
[TBL] [Abstract][Full Text] [Related]
8. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
10. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
Eltayb A; Wadenberg ML; Svensson TH
Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
[TBL] [Abstract][Full Text] [Related]
12. Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.
Khokhar JY; Green AI
Neuropharmacology; 2016 Jun; 105():25-34. PubMed ID: 26796639
[TBL] [Abstract][Full Text] [Related]
13. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
14. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
16. Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice.
Aguilar MA; Marí-Sanmillán MI; Morant-Deusa JJ; Miñarro J
Behav Neurosci; 2000 Apr; 114(2):389-400. PubMed ID: 10832799
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
18. Non-competitive interaction between raclopride and spiperone on human D-receptors in intact Chinese hamster ovary cells.
Packeu A; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):283-91. PubMed ID: 19909349
[TBL] [Abstract][Full Text] [Related]
19. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
Malmberg A; Jackson DM; Eriksson A; Mohell N
Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
[TBL] [Abstract][Full Text] [Related]
20. The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat.
Chau DT; Khokhar JY; Dawson R; Ahmed J; Xie H; Green AI
Alcohol; 2013 Dec; 47(8):611-8. PubMed ID: 24280363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
